European Journal of Pediatrics

, Volume 173, Issue 9, pp 1147–1155 | Cite as

Socio-economic differences in use of prescribed and over-the-counter medicine for pain and psychological problems among Danish adolescents—a longitudinal study

  • Mette Jorgine Kirkeby
  • Claus Dalsgaard Hansen
  • Johan Hviid Andersen
Original Article
  • 202 Downloads

Abstract

The objective for this study was to investigate socio-economic status (SES) differentials in the use of over-the-counter and prescribed medicine for pain and psychological problems among adolescents. Data consisted of questionnaire data on medicine use and health status, collected from 17- to 18-year-old adolescents (n = 2,400) during second round of the West Jutland cohort study 2007, and register data on prescribed medicine use, parental educational level and household income. We used multiple logistic regression analysis to calculate odd ratios for self-reported and register-based use of medicine for pain and psychological problems according to parental educational level and household income. Young girls used twice as much medicine for pain and psychological problems compared to young boys. SES differences based on parental educational level were directly associated with the use of prescribed medicine for psychological problems, and SES differences based on household income were directly associated with overall medicine use and use of over-the-counter medicine. Some of the SES differentials disappeared or decreased after adjusting for health status. There were no SES differentials in the use of prescribed medicine for pain. Conclusion: The risk of use of prescribed medicine for psychological problems increased in adolescents with decreasing parental education, while the risk of overall medicine use and use of over-the-counter medicine was increased in adolescents from low household income. Furthermore, the results indicate that some of the SES differentials in medicine use could be explained by a difference in health status across SES.

Keywords

Youth Medication Socio-economic status Cohort study Register data 

References

  1. 1.
    Christiansen M, Hansen CD, Glasscock D, Andersen JH (2010) Social inequality and health in adolescents. Ugeskr Laeger 172(11):857–863PubMedGoogle Scholar
  2. 2.
    Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396PubMedCrossRefGoogle Scholar
  3. 3.
    Croghan TW (2001) The controversy of increased spending for antidepressants. Health Aff Millwood 20(2):129–135PubMedCrossRefGoogle Scholar
  4. 4.
    Croghan TW, Schoenbaum M, Sherbourne CD, Koegel P (2006) A framework to improve the quality of treatment for depression in primary care. Psychiatr Serv 57(5):623–630PubMedCrossRefGoogle Scholar
  5. 5.
    Currie CE, Elton RA, Todd J, Platt S (1997) Indicators of socioeconomic status for adolescents: the WHO health behaviour in school-aged children survey. Health Educ Res 12(3):385–397PubMedCrossRefGoogle Scholar
  6. 6.
    Derogatis LR, Cleary PA (1977) Confirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psychol 33:981–989CrossRefGoogle Scholar
  7. 7.
    Due P, Hansen EH, Merlo J, Andersen A, Holstein BE (2007) Is victimization from bullying associated with medicine use among adolescents? A nationally representative cross-sectional survey in Denmark. Pediatrics 120(1):110–117PubMedCrossRefGoogle Scholar
  8. 8.
    Fendrich M, Weissman MM, Warner V (1990) Screening for depressive disorder in children and adolescents: validating the center for epidemiologic studies depression scale for children. Am J Epidemiol 131(3):538–551PubMedGoogle Scholar
  9. 9.
    Glasscock DJ, Andersen JH, Labriola M, Rasmussen K, Hansen CD (2013) Can negative life events and coping style help explain socioeconomic differences in perceived stress among adolescents? A cross-sectional study based on the West Jutland cohort study. BMC Public Health 13(1):532PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Hansen DL, Hansen EH, Holstein BE (2008) Using analgesics as tools: young women’s treatment for headache. Qual Health Res 18(2):234–243PubMedCrossRefGoogle Scholar
  11. 11.
    Hansen DL, Hansen EH, Holstein BE (2009) Young women’s use of medicines: autonomy and positioning in relation to family and peer norms. Health (London) 13(4):467–485CrossRefGoogle Scholar
  12. 12.
    Hansen EH, Holstein BE, Due P, Currie CE (2003) International survey of self-reported medicine use among adolescents. Ann Pharmacother 37(3):361–366PubMedCrossRefGoogle Scholar
  13. 13.
    Holstein BE, Andersen A, Krolner R, Due P, Hansen EH (2008) Young adolescents’ use of medicine for headache: sources of supply, availability and accessibility at home. Pharmacoepidemiol Drug Saf 17(4):406–410PubMedCrossRefGoogle Scholar
  14. 14.
    Holstein BE, Currie C, Boyce W et al (2009) Socio-economic inequality in multiple health complaints among adolescents: international comparative study in 37 countries. Int J Public Health 54(Suppl 2):260–270PubMedCrossRefGoogle Scholar
  15. 15.
    Holstein BE, Hansen EH (2005) Self-reported medicine use among adolescents from ethnic minority groups. Eur J Clin Pharmacol 61(1):69–70PubMedCrossRefGoogle Scholar
  16. 16.
    Holstein BE, Hansen EH, Due P (2004) Social class variation in medicine use among adolescents. Eur J Public Health 14(1):49–52PubMedCrossRefGoogle Scholar
  17. 17.
    Idler EL, Benyamini Y (1997) Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 38(1):21–37PubMedCrossRefGoogle Scholar
  18. 18.
    Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U (1999) Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a swedish prescription database. J Affect Disord 53(1):15–22PubMedCrossRefGoogle Scholar
  19. 19.
    Jureidini J, Tonkin A (2006) Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 20(8):623–632PubMedCrossRefGoogle Scholar
  20. 20.
    Kildemoes HW, Sorensen HT, Hallas J (2011) The Danish national prescription registry. Scand J Public Health 39(7 Suppl):38–41PubMedCrossRefGoogle Scholar
  21. 21.
    Koushede V, Ekholm O, Holstein BE, Andersen A, Hansen EH (2011) Stress and use of over-the-counter analgesics: prevalence and association among Danish 25 to 44-year-olds from 1994 to 2005. Int J Public Health 56(1):81–87PubMedCrossRefGoogle Scholar
  22. 22.
    Macintyre S, McKay L, Der G, Hiscock R (2003) Socio-economic position and health: what you observe depends on how you measure it. J Public Health Med 25(4):288–294PubMedCrossRefGoogle Scholar
  23. 23.
    Macintyre S, West P (1991) Lack of class variation in health in adolescence: an artefact of an occupational measure of social class? Soc Sci Med 32(4):395–402PubMedCrossRefGoogle Scholar
  24. 24.
    Maiman LA, Becker MH, Katlic AW (1986) Correlates of mothers’ use of medications for their children. Soc Sci Med 22(1):41–51PubMedCrossRefGoogle Scholar
  25. 25.
    Matzke GR (1996) Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents. Am J Kidney Dis 28(1 Suppl 1):S63–S70PubMedCrossRefGoogle Scholar
  26. 26.
    Pedersen CB (2011) The Danish Civil Registration System. Scand J Public Health 39(7 Suppl):22–25PubMedCrossRefGoogle Scholar
  27. 27.
    Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, van Suijlekom-Smit LW, Passchier J, van der Wouden JC (2000) Chronic pain among children and adolescents: physician consultation and medication use. Clin J Pain 16(3):229–235PubMedCrossRefGoogle Scholar
  28. 28.
    Rasmussen M, Due P (2011) Skolebørnsundersøgelsen 2010. 1′1′. Statens Institut for Folkesundhed, Syddansk Universitet, KøbenhavnGoogle Scholar
  29. 29.
    Ravens-Sieberer U, Torsheim T, Hetland J et al (2009) Subjective health, symptom load and quality of life of children and adolescents in Europe. Int J Public Health 54(Suppl 2):151–159PubMedCrossRefGoogle Scholar
  30. 30.
    Stoelben S, Krappweis J, Rossler G, Kirch W (2000) Adolescents’ drug use and drug knowledge. Eur J Pediatr 159(8):608–614PubMedCrossRefGoogle Scholar
  31. 31.
    Sweetman SC (2011) Martindale: the complete drug reference, 37th edn. Pharmaceutical Press, LondonGoogle Scholar
  32. 32.
    Tobi H, Meijer WM, Tuinstra J, de Jong-van den Berg LT (2003) Socio-economic differences in prescription and OTC drug use in Dutch adolescents. Pharm World Sci 25(5):203–206PubMedCrossRefGoogle Scholar
  33. 33.
    Viner RM, Ozer EM, Denny S et al (2012) Adolescence and the social determinants of health. Lancet 379(9826):1641–1652PubMedCrossRefGoogle Scholar
  34. 34.
    von Soest T, Bramness JG, Pedersen W, Wichstrom L (2012) The relationship between socio-economic status and antidepressant prescription: a longitudinal survey and register study of young adults. Epidemiol Psychiatr Sci 21(1):87–95CrossRefGoogle Scholar
  35. 35.
    West P (1988) Inequalities? Social class differentials in health in British youth. Soc Sci Med 27(4):291–296PubMedCrossRefGoogle Scholar
  36. 36.
    West P, Sweeting H, Young R, Kelly S (2010) The relative importance of family socioeconomic status and school-based peer hierarchies for morning cortisol in youth: an exploratory study. Soc Sci Med 70(8):1246–1253PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Mette Jorgine Kirkeby
    • 1
  • Claus Dalsgaard Hansen
    • 2
  • Johan Hviid Andersen
    • 3
  1. 1.Department of Occupational MedicineRegional Hospital HerningHerningDenmark
  2. 2.Department of Sociology and Social WorkAalborg UniversityAalborgDenmark
  3. 3.Danish Ramazzini Centre, Department of Occupational MedicineRegional Hospital, HerningHerningDenmark

Personalised recommendations